NCT02136355View on ClinicalTrials.gov

A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 25, 2022

Study Completion Date

November 25, 2022

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy plus Surgery

Stereotactic body radiation therapy followed by surgical resection

Trial Locations (1)

N6A 4L6

London Regional Cancer Program of the Lawson Health Research Institute, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02136355 - A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter